Prevalence of exonic CNVs in ACMG 59 genes
Unlike SNVs and indels, CNVs are not always reported as part of a healthy population screen or secondary findings analysis. Here, we present evidence that they should be, as 0.4% of the ~30,000 healthy individuals enrolled in the Healthy Nevada Project (HNP) were found to have CNV variants in ACMG 59 genes—showcasing the potential clinical impact of adding a CNV analysis to a screening program.
Helix Research
Related work
A comprehensive landscape of CYP2D6 variation across 30,000 individuals
Typical commercial PGx tests are at risk of misgenotyping 17% of people because they only call the most common CYP2D6 star alleles. Helix’s Exome+® assay reports >100 star alleles with an average accuracy of 99.5%. Learn more from our results here.
